Reference:
Chatterjee, A., & Chakravarty, A. (2022). Neurological complications following COVID‑19 vaccination. Current Neurology and Neuroscience Reports, 22(1), 1-14. https://doi.org/10.1007/s11910-022-01247-x
Summary:
This article reviews neurological complications associated with COVID-19 vaccination, which may contribute to vaccine hesitancy. Adverse events such as cortical sinus venous thrombosis, Guillain–Barré syndrome, and transverse myelitis are considered serious, though their overall incidence remains low compared to vaccination rates. Common mild effects include headaches and fatigue. The authors emphasise that while some neurological adverse events have been documented, they are rare and typically transient. The evidence suggests that the benefits of vaccination, particularly in preventing severe COVID-19, outweigh the risks of these events. Vaccination is deemed safe for individuals with pre-existing neurological conditions, although caution is advised for those with a history of thrombotic events. The authors conclude that effective vaccination strategies are essential to combat the ongoing pandemic despite the potential for adverse neurological reactions.